Princeton Capital Management Inc’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Princeton Capital Management Inc’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-34,825	Closed	-$177K	–	78
2016 Q2	$177K	Hold	34,825	–	–	0.12%	69
2016 Q1	$199K	Hold	34,825	–	–	0.14%	65
2015 Q4	$361K	Hold	34,825	–	–	0.25%	52
2015 Q3	$643K	Hold	34,825	–	–	0.39%	45
2015 Q2	$678K	Hold	34,825	–	–	0.36%	46
2015 Q1	$612K	Sell	34,825 -1,300	-4%	-$21.8K	0.31%	47
2014 Q4	$578K	Buy	36,125 +300	+0.8%	+$4.02K	0.32%	50
2014 Q3	$451K	Hold	35,825	–	–	0.29%	55
2014 Q2	$560K	Buy	35,825 +8,050	+29%	+$118K	0.39%	56
2014 Q1	$365K	Buy	27,775 +1,400	+5%	+$21.9K	0.26%	63
2013 Q4	$424K	Buy	26,375 +500	+2%	+$7.97K	0.34%	59
2013 Q3	$431K	Buy	25,875 +5,000	+24%	+$73.9K	0.39%	57
2013 Q2	$210K	Buy	+20,875	New	+$219K	0.2%	64

Other funds holding OSIR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Princeton Capital Management Inc's OSIR Position: Q3 2016 in Review

Princeton Capital Management Inc sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2016, closing a stake of 34,825 shares — an estimated $177K sold.

Princeton Capital Management Inc first reported a position in OSIR in Q2 2013 and held it in 13 quarters. The position peaked at $678K in Q2 2015. 63 funds tracked by Wall St. Rank hold OSIR as of Q3 2016.

Princeton Capital Management Inc reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Princeton Capital Management Inc sold 34,825 Osiris Therapeutics, Inc. Common Stock shares in Q3 2016, an estimated $177K.
Princeton Capital Management Inc first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
Princeton Capital Management Inc's Osiris Therapeutics, Inc. Common Stock position peaked at $678K in Q2 2015.
63 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2016.

Based on Princeton Capital Management Inc's 13F filing for Q3 2016, filed 3 Nov 2016.